Drugs / Dopexamine

Trials 2 · a red edge is where a trial was stopped

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00134212 Mar 2002 → Jun 2004 infectious disease with sepsis Rennes University Hospital Completed No outcome recorded
Phase 41 trial
Phase 4 NCT01418118 Oct 2008 → Feb 2010 head and neck cancer, hypotensive disorder, oral cavity cancer Oxford University Hospitals NHS Trust Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Dopexamine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01418118
1

NCT00134212

Known as Dopacard ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as Dopexamina ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as Dopexamine dihydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as Dopexamine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as DOPEXAMINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as FPL 60278 ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Known as FPL 60278AR ChEMBL registry synonym — accepted as the source's own label CHEMBL77622
Modality Other / unclassified “Dopexamine is a structural and synthetic analog of dopamine” NCT00134212